Intuitive Surgical, Inc. $ISRG Shares Newly Purchased by Quantum Capital Management LLC NJ

Quantum Capital Management LLC NJ purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 19,990 shares of the medical equipment provider’s stock, valued at approximately $8,129,000. Intuitive Surgical comprises 1.0% of Quantum Capital Management LLC NJ’s investment portfolio, making the stock its 20th biggest holding.

A number of other institutional investors have also made changes to their positions in ISRG. AlphaGrep UK Ltd lifted its holdings in shares of Intuitive Surgical by 33.6% during the third quarter. AlphaGrep UK Ltd now owns 1,256 shares of the medical equipment provider’s stock worth $511,000 after buying an additional 316 shares during the last quarter. Meeder Advisory Services Inc. boosted its position in shares of Intuitive Surgical by 9.3% in the third quarter. Meeder Advisory Services Inc. now owns 8,877 shares of the medical equipment provider’s stock valued at $3,610,000 after acquiring an additional 757 shares during the period. CacheTech Inc. boosted its position in shares of Intuitive Surgical by 31.5% in the third quarter. CacheTech Inc. now owns 11,686 shares of the medical equipment provider’s stock valued at $4,752,000 after acquiring an additional 2,798 shares during the period. BNP Paribas grew its stake in shares of Intuitive Surgical by 7.3% in the third quarter. BNP Paribas now owns 31,694 shares of the medical equipment provider’s stock worth $12,888,000 after acquiring an additional 2,153 shares during the last quarter. Finally, Jackson Thornton Wealth Management LLC acquired a new stake in shares of Intuitive Surgical in the third quarter worth $368,000. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Craig H. Barratt sold 1,150 shares of the stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $460.00, for a total value of $529,000.00. Following the completion of the transaction, the director owned 1,150 shares of the company’s stock, valued at $529,000. This represents a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $457.34, for a total transaction of $4,573,400.00. Following the transaction, the director owned 1,194,530 shares of the company’s stock, valued at approximately $546,306,350.20. This represents a 0.83% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 39,363 shares of company stock worth $17,738,749 in the last 90 days. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

ISRG opened at $399.06 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The firm’s fifty day moving average price is $423.51 and its two-hundred day moving average price is $427.91. The company has a market capitalization of $138.33 billion, a P/E ratio of 48.25, a P/E/G ratio of 2.75 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. During the same quarter in the prior year, the company posted $2.40 EPS. The business’s revenue was up 21.7% on a year-over-year basis. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Key Headlines Impacting Intuitive Surgical

Here are a few of the latest headlines about ISRG:

  • Positive Sentiment: A BTIG Research analyst reportedly expects ISRG shares to rise, providing a positive analyst signal; the headline does not specify a price target or the reasoning. BTIG analyst article
  • Positive Sentiment: Industry coverage casts Intuitive Surgical as a leading beneficiary of expanding surgical-robotics adoption, citing growth in robotic procedures and use of its da Vinci system. A separate medical-device roundup also identifies ISRG as a stock to watch, though neither story reports a new company announcement. Surgical robotics industry article Medical-device stocks article
  • Neutral Sentiment: Options-market coverage notes activity that investors may want to watch, but provides no clear directional conclusion or confirmed catalyst. Options-market article

Analyst Ratings Changes

ISRG has been the topic of a number of research reports. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. BMO Capital Markets reissued an “outperform” rating on shares of Intuitive Surgical in a report on Tuesday. Leerink Partners set a $503.00 price target on shares of Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday, October 21st. KeyCorp restated an “overweight” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Finally, BTIG Research boosted their price objective on shares of Intuitive Surgical from $454.00 to $513.00 and gave the stock a “buy” rating in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $495.90.

View Our Latest Stock Report on Intuitive Surgical

About Intuitive Surgical

(Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.

Featured Articles

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.